MicroRNA mediated signaling and metabolic reprogramming in oral squamous cell carcinoma

Scott SE, Grunfeld EA, McGurk M. The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma. Oral Oncol. 2005;41:396–403. https://doi.org/10.1016/j.oraloncology.2004.10.010.

Article  CAS  PubMed  Google Scholar 

Silvermam S. Demographics and occurrence of oral and pharyngeal cancers: the outcomes, the trends, the challenge. J Am Dent Assoc. 2001;132:S7–11. https://doi.org/10.14219/jada.archive.2001.0382.

Article  Google Scholar 

Liu CJ, Liu TY, Kuo LT, et al. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. J Pathol. 2008;214:489–97. https://doi.org/10.1002/PATH.2306.

Article  CAS  PubMed  Google Scholar 

Padma R, Kalaivani A, Sundaresan S, Sathish P. The relationship between histological differentiation and disease recurrence of primary oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2017;21:461. https://doi.org/10.4103/JOMFP.JOMFP_241_16.

Article  PubMed  PubMed Central  Google Scholar 

Walden MJ, Aygun N. Head and neck cancer. Semin Roentgenol. 2013;48:75–86. https://doi.org/10.1053/J.RO.2012.09.002.

Article  PubMed  Google Scholar 

Bartel DP. Metazoan MicroRNAs. Cell. 2018;173:20–51. https://doi.org/10.1016/j.cell.2018.03.006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McManus MT. MicroRNAs and cancer. Semin Cancer Biol. 2003;13:253–8. https://doi.org/10.1016/S1044-579X(03)00038-5.

Article  CAS  PubMed  Google Scholar 

Gantier MP, McCoy CE, Rusinova I, et al. Analysis of MicroRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 2011;39:5692–703. https://doi.org/10.1093/NAR/GKR148.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muth DC, Powell BH, Zhao Z, Witwer KW. (2018) miRNAs in platelet-poor blood plasma and purified RNA are highly stable: a confirmatory study. BMC Research Notes 2018;11:(1) 273. https://doi.org/10.1186/S13104-018-3378-6

Article  PubMed  PubMed Central  Google Scholar 

Clark MB, Johnston RL, Inostroza-Ponta M, et al. Genome-wide analysis of long noncoding RNA stability. Genome Res. 2012;22:885–98. https://doi.org/10.1101/GR.131037.111.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu BH, Xiong XP, Jia J, Zhang WF. MicroRNAs: new actors in the oral cancer scene. Oral Oncol. 2011;47:314–9. https://doi.org/10.1016/J.ORALONCOLOGY.2011.03.019.

Article  CAS  PubMed  Google Scholar 

Yong SL, Dutta A. The tumor suppressor MicroRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007;21:1025–30. https://doi.org/10.1101/GAD.1540407.

Article  Google Scholar 

Aali M, Mesgarzadeh AH, Najjary S, et al. Evaluating the role of MicroRNAs alterations in oral squamous cell carcinoma. Gene. 2020;757:144936. https://doi.org/10.1016/j.gene.2020.144936.

Article  CAS  PubMed  Google Scholar 

Schickel R, Boyerinas B, SM P, Peter M. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene. 2008;27:5959–74. https://doi.org/10.1038/ONC.2008.274.

Article  CAS  PubMed  Google Scholar 

Carreira-Barbosa F, Nunes SC. Wnt signaling: paths for cancer progression. Adv Exp Med Biol. 2020;1219:189–202. https://doi.org/10.1007/978-3-030-34025-4_10.

Article  CAS  PubMed  Google Scholar 

Niehrs C. The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol. 2012;13:767–79. https://doi.org/10.1038/NRM3470.

Article  CAS  PubMed  Google Scholar 

Willert K, Nusse R. Wnt proteins. Cold Spring Harb Perspect Biol. 2012. https://doi.org/10.1101/CSHPERSPECT.A007864. 4:.

Article  PubMed  PubMed Central  Google Scholar 

Lowy AM, Fenoglio-Preiser C, Kim OJ, et al. Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma. Ann Surg Oncol. 2003;10:284–90. https://doi.org/10.1245/ASO.2003.05.003.

Article  PubMed  Google Scholar 

Xie J, Huang L, Lu Y-G, Zheng D-L. Roles of the Wnt signaling pathway in head and neck squamous cell carcinoma. Front Mol Biosci. 2020;7:590912. https://doi.org/10.3389/fmolb.2020.590912.

Article  CAS  PubMed  Google Scholar 

El-Sahli S, Xie Y, Wang L, Liu S. Wnt signaling in cancer metabolism and immunity. Cancers (Basel). 2019;11:904. https://doi.org/10.3390/CANCERS11070904.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang KL, Tang HY, Du Y, et al. MiR-638 suppresses the progression of oral squamous cell carcinoma through wnt/β-catenin pathway by targeting phospholipase D1. Artif Cells Nanomed Biotechnol. 2019;47:3278–85. https://doi.org/10.1080/21691401.2019.1647222.

Article  CAS  PubMed  Google Scholar 

García-Jiménez C, García-Martínez JM, Chocarro-Calvo A, De la Vieja A. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose. J Mol Endocrinol. 2013;52. https://doi.org/10.1530/JME-13-0152.

Wei Z, Wang Y, Jiang L, et al. miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt/β-catenin signaling pathway. Oral Oncol. 2020;109. https://doi.org/10.1016/j.oraloncology.2020.104941.

Jiang Q, Cao Y, Qiu Y, et al. Progression of squamous cell carcinoma is regulated by miR-139-5p/CXCR4. Front Bioscience - Landmark. 2020;25:1732–45. https://doi.org/10.2741/4875.

Article  CAS  Google Scholar 

Wang T, Guo S, Liu Z, et al. CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling. Oncotarget. 2014;5:10293–306. https://doi.org/10.18632/ONCOTARGET.2511.

Article  PubMed  PubMed Central  Google Scholar 

Chatterjee S, Behnam Azad B, Nimmagadda S. The intricate role of CXCR4 in cancer. Adv Cancer Res. 2014;124:31–82. https://doi.org/10.1016/B978-0-12-411638-2.00002-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schioppa T, Uranchimeg B, Saccani A, et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med. 2003;198:1391–402. https://doi.org/10.1084/JEM.20030267.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li GH, Ma ZH, Wang X. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway. Cell Cycle. 2019;18:2902–13. https://doi.org/10.1080/15384101.2019.1662257.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu L, Jiang H, Zhao J, Wen H. MiRNA-16 inhibited oral squamous carcinoma tumor growth in vitro and in vivo via suppressing Wnt/β-catenin signaling pathway. Onco Targets Ther. 2018;11:5111–9. https://doi.org/10.2147/OTT.S153888.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pashirzad M, Fiuji H, Khazei M, et al. Role of Wnt3a in the pathogenesis of cancer, current status and prospective. Mol Biol Rep. 2019;46:5609–16. https://doi.org/10.1007/S11033-019-04895-4.

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif